Clinical Trials Browser

Phase 2 × Recruiting × Klatskin Tumor × Clear all

NCT05430698 2026-02-09

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Phase 2 Recruiting

Gastrointestinal

Klatskin Tumor